Our new profile is COBI, Compass Biotechnologies Inc.
We are very excited about this company. The stars do appear to be aligned on this one. Here is why we think this one could be a BIG money maker for our members...
COBI is very close to 52 week lows right now.
Excerpt from the latest filing "The Company has had a change of control as of March 16th, 2012" (nothing officially announced yet)
Freely tradable shares (Public Float) is only 35,296,364.
Biotechnology is a hot sector right now.
Patented biotechnology (see excerpt below).
"In January 2010 we were assigned an exclusive worldwide license from the
National Institutes of Health (NIH) for a technology based on using virus like
particles (VLPs) to produce vaccines. The first license we decided to develop
was to use the VLP technology to develop a vaccine for Hepatitis C. We also
decided to develop generic products using different formulations off the off
patent drugs Ribavirin and alpha interferon. These two drugs are the current
standard of care for Hepatitis C and represent a global US$2 billion a year
market."
Business Development: Compass is structured as a Biotechnology research
and development company, focusing on the development and commercialization of generic, bio-similar and bio-better drug products.
Generic drugs are duplicates of small molecule or chemical compounds and
are well established in the pharmaceutical industry. Bio-similiars are protein
drugs which are close duplicates of the originally marketed protein drug but
are not exact replicas. A "biobetter" is a biopharmaceutical product that is a
copy of an existing product but is designed to have superior efficacy, safety,
or improved drug delivery characteristics compared to the original product.
Biobetter drugs, are subject to full clinical trials but the cost, time and risk in getting them to market are lower; as the base component of the drug (the
protein component) is already well known, characterized and accepted by
regulatory agencies like the US Food and Drug Administration (FDA).
Markets and their sizes are already established.
Share Structure
Market Value1 $1,416,307 a/o Apr 17, 2012
Shares Outstanding 162,793,948 a/o Apr 03, 2012
Float 35,296,364
Authorized Shares 250,000,000 a/o Mar 15, 2012
Par Value 0.001
As always working hard to live up to our name FIRSTpennypicks.com
happy trading, The TEAM AT FPP
Firstpennypicks.com employees own a combined total of 150K shares of COBI and may sell them at anytime during or after our profile of COBI.
Penny stocks are coming to the attention of many investors. This comes as no surprise considering the many benefits of investing in what others also call micro-cap stocks and nano stocks. For one thing, you can invest a relatively small amount of money to own a lot of stocks that can provide for a huge profit later on. For another thing, you can hone your trading and investing skills with penny stocks before deciding to trade on the big boards.
